Their results showed that CD97 mAb administration caused retarded neutrophil migration to sites of inflammation in vivo and thus impaired anti-bacterial host defense and survival [94], attenuated inflammatory responses to experimental arthritis [95], and reduced stem cell mobilization from bone marrow [96]. Here, ADGRE2 is linked to arthritic joint disease.